{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:58:02Z","timestamp":1790355482389,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xphs.2024.10.019","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:46:59Z","timestamp":1729259219000},"page":"424-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of the impact of the polymer end groups and molecular weight on in vitro and in vivo performances of PLGA based in situ forming implants for ketoprofen"],"prefix":"10.1016","volume":"114","author":[{"given":"Sanjib","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3819-5509","authenticated-orcid":false,"given":"Xinhao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9833-8358","authenticated-orcid":false,"given":"Eric","family":"Gosselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-9011","authenticated-orcid":false,"given":"Paresh P.","family":"Chothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mittal","family":"Darji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4591-5007","authenticated-orcid":false,"given":"Wenzhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2024.10.019_bib0001","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2012.04.016","article-title":"In situ forming implants - an attractive formulation principle for parenteral depot formulations","volume":"161","author":"Kempe","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2024.10.019_bib0002","unstructured":"Injectable depot drug delivery technologies. May 15, 2023. https:\/\/www.pharmacircle.com\/app\/reviews.php. Accessed June 21, 2024."},{"key":"10.1016\/j.xphs.2024.10.019_bib0003","unstructured":"Drugs@FDA: FDA-approved drugs. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm. Accessed June 21, 2024."},{"issue":"1","key":"10.1016\/j.xphs.2024.10.019_bib0004","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","article-title":"PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release","volume":"172","author":"Parent","year":"2013","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.019_bib0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/03639045.2012.746360","article-title":"Development of meloxicam in situ implant formulation by quality by design principle","volume":"40","author":"Ibrahim","year":"2014","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.019_bib0006","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jconrel.2010.08.020","article-title":"Effect of injection site on in situ implant formation and drug release in vivo","volume":"147","author":"Patel","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2024.10.019_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120105","article-title":"Effect of implant formation on drug release kinetics of in situ forming implants","volume":"592","author":"Suh","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2024.10.019_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113912","article-title":"Drug release from in situ forming implants and advances in release testing","volume":"178","author":"Wang","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2024.10.019_bib0009","unstructured":"Non-clinical Reviews. 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210655Orig1s000PharmR.pdf. Accessed June 21, 2024."},{"issue":"10","key":"10.1016\/j.xphs.2024.10.019_bib0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/10837450.2021.1985519","article-title":"Experimental design, development and evaluation of extended release subcutaneous thermo-responsive in situ gels for small molecules in drug discovery","volume":"26","author":"Sharma","year":"2021","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2024.10.019_bib0011","unstructured":"Berkeley UoCa. https:\/\/berkeley-madonna.myshopify.com\/, 2024."},{"issue":"15","key":"10.1016\/j.xphs.2024.10.019_bib0012","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0142-9612(95)93575-X","article-title":"Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition","volume":"16","author":"Park","year":"1995","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.019_bib0013","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F","article-title":"In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films","volume":"46","author":"Lu","year":"1999","journal-title":"J Biomed Mater Res"},{"issue":"6","key":"10.1016\/j.xphs.2024.10.019_bib0014","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0731-7085(95)01276-Q","article-title":"Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres","volume":"13","author":"Hausberger","year":"1995","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.019_bib0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s13346-021-01023-3","article-title":"Characterization of commercial PLGAs by NMR spectroscopy","volume":"12","author":"Sun","year":"2022","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.019_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2015.08.063","article-title":"A protocol for assay of poly(lactide-co-glycolide) in clinical products","volume":"495","author":"Garner","year":"2015","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.019_bib0017","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/ijms15033640","article-title":"An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering","volume":"15","author":"Gentile","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.019_bib0018","doi-asserted-by":"crossref","DOI":"10.1063\/1.5021217","article-title":"Solubility and dissolution improvement of ketoprofen by emulsification ionic gelation","volume":"1927","author":"Rachmaniar","year":"2018","journal-title":"AIP Conf Proc"},{"issue":"3","key":"10.1016\/j.xphs.2024.10.019_bib0019","first-page":"159","article-title":"A comparison of theoretical methods of calculation of partition coefficients for selected drugs","volume":"63","author":"Pyka","year":"2006","journal-title":"Acta Pol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.10.019_bib0020","article-title":"Determination of the lipophilicity of ibuprofen, naproxen, ketoprofen, and flurbiprofen with thin-layer chromatography","volume":"2019","author":"Czyrski","year":"2019","journal-title":"J Chem"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.10.019_bib0021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.01.053","article-title":"Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems","volume":"357","author":"Tang","year":"2008","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.10.019_bib0022","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2004.10.019","article-title":"Controlled release from bioerodible polymers: effect of drug type and polymer composition","volume":"102","author":"Frank","year":"2005","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.xphs.2024.10.019_bib0023","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1002\/jps.23250","article-title":"Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol","volume":"101","author":"Ahmed","year":"2012","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924004490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T01:36:04Z","timestamp":1734744964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924004490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022354924004490"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.019","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the impact of the polymer end groups and molecular weight on in vitro and in vivo performances of PLGA based in situ forming implants for ketoprofen","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}